ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed

April 5, 1985

Fogarty Leads Grant Program On World Tobacco Research.

July 6, 2001

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002